We have validated anti-factor IIa and anti-factor Xa potency assays for low-molecular weight heparin and unfractionated heparin in-house. These validations were performed in accordance with valid pharmacopoeias (USP, EP, BP) and individual solutions for customers. This means we can offer a choice of several anti-factor IIa and Xa methods. Our many international customers have been relying on this service for years in their release of finished products, raw materials, in-process controls and stability testing.

  • Batch release analytics for raw materials and finished products
  • Low molecular weight heparin
  • Unfractionated heparin
  • Anti-factor IIa assay
  • Anti-factor Xa assay
  • Stability analysis


If you would like to start talking about how we can help you, or if you’re still not sure if we can address your needs and you have questions, don’t hesitate to get in touch with us.